Parrot David
SEC insider (Form 3/4/5 filer). CIK 0002127908. Chief Financial Officer at Scribe Therapeutics, Inc. (SCTX). 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 23, 2026. Located in ALAMEDA, CA.
Companies Parrot David has filed insider reports for
- Scribe Therapeutics, Inc. (SCTX): Officer, Chief Financial Officer
Parrot David
CIK: 0002127908
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Scribe Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jul 23, 2026SCTX
Scribe Therapeutics, Inc.
PurchaseIndirect1.3K shares at avg. $15.00$20K - Jul 23, 2026SCTX
Scribe Therapeutics, Inc.
PurchaseIndirect1.3K shares at avg. $15.00$20K - Jul 23, 2026SCTX
Scribe Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
109.4K shares- - Jul 23, 2026SCTX
Scribe Therapeutics, Inc.
AwardDirectPerformance-based Stock Option (Right to Buy)
109.4K shares- - Mar 13, 2026SCTX
Scribe Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
8.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 23, 2026 | SCTX Scribe Therapeutics, Inc. | Purchase | 1,333 | $15.00 | $19,995 | Indirect |
| Jul 23, 2026 | SCTX Scribe Therapeutics, Inc. | Purchase | 1,333 | $15.00 | $19,995 | Indirect |
| Jul 23, 2026 | SCTX Scribe Therapeutics, Inc. | Award Stock Option (Right to Buy) | 109,426 | - | - | Direct |
| Jul 23, 2026 | SCTX Scribe Therapeutics, Inc. | Award Performance-based Stock Option (Right to Buy) | 109,426 | - | - | Direct |
| Mar 13, 2026 | SCTX Scribe Therapeutics, Inc. | Award Stock Option (Right to Buy) | 8,909 | - | - | Direct |
1-5 of 5 transactions